A 0 1 0 1 O
requirement 2 13 2 13 O
for 14 17 14 17 O
daily 18 23 18 23 O
systemic 24 32 24 32 B-treatment
corticosteroids 33 48 33 48 I-treatment
for 49 52 49 52 O
any 53 56 53 56 O
reason 57 63 57 63 O
or 64 66 64 66 O
a 67 68 67 68 O
requirement 69 80 69 80 O
for 81 84 81 84 O
other 85 90 85 90 O
immunosuppressive 91 108 91 108 B-treatment
or 109 111 109 111 O
immunomodulatory 112 128 112 128 B-treatment
agents 129 135 129 135 I-treatment

Absolute 0 8 136 144 B-clinical_variable
neutrophil 9 19 145 155 I-clinical_variable
count 20 25 156 161 I-clinical_variable
≥1500 26 31 162 167 O
neutrophils 32 43 168 179 I-lower_bound
/ 43 44 179 180 I-lower_bound
mm3 44 47 180 183 I-lower_bound

Administration 0 14 184 198 O
of 15 17 199 201 O
live 18 22 202 206 O
, 22 23 206 207 O
attenuated 24 34 208 218 B-treatment
vaccine 35 42 219 226 I-treatment
within 43 49 227 233 O
8 50 51 234 235 B-upper_bound
weeks 52 57 236 241 I-upper_bound
before 58 64 242 248 I-upper_bound
the 65 68 249 252 O
start 69 74 253 258 O
of 75 77 259 261 O
treatment 78 87 262 271 B-treatment
( 88 89 272 273 O
day 89 92 273 276 O
0 93 94 277 278 O
) 94 95 278 279 O
and 96 99 280 283 O
throughout 100 110 284 294 O
the 111 114 295 298 O
study 115 120 299 304 O

All 0 3 305 308 O
acute 4 9 309 314 O
toxic 10 15 315 320 O
effects 16 23 321 328 O
of 24 26 329 331 O
any 27 30 332 335 O
previous 31 39 336 344 O
radiotherapy 40 52 345 357 B-treatment
, 52 53 357 358 O
chemotherapy 54 66 359 371 B-treatment
, 66 67 371 372 O
or 68 70 373 375 O
surgical 71 79 376 384 B-treatment
procedures 80 90 385 395 I-treatment
must 91 95 396 400 O
have 96 100 401 405 O
resolved 101 109 406 414 O
to 110 112 415 417 O
grade 113 118 418 423 B-upper_bound
I 119 120 424 425 I-upper_bound
or 121 123 426 428 O
lower 124 129 429 434 O
according 130 139 435 444 O
to 140 142 445 447 O
CTCAE 143 148 448 453 O
( 149 150 454 455 O
version 150 157 455 462 O
4.0 158 161 463 466 O
) 161 162 466 467 O

An 0 2 468 470 O
infection 3 12 471 480 O
requiring 13 22 481 490 O
antibiotic 23 33 491 501 B-treatment
treatment 34 43 502 511 I-treatment
within 44 50 512 518 O
7 51 52 519 520 B-upper_bound
days 53 57 521 525 I-upper_bound
before 58 64 526 532 I-upper_bound
the 65 68 533 536 O
start 69 74 537 542 O
of 75 77 543 545 O
treatment 78 87 546 555 O
( 88 89 556 557 O
day 89 92 557 560 O
0 93 94 561 562 O
) 94 95 562 563 O

Any 0 3 564 567 O
major 4 9 568 573 B-treatment
thoracic 10 18 574 582 I-treatment
( 19 20 583 584 O
thoracotomy 20 31 584 595 B-treatment
with 32 36 596 600 O
lung 37 41 601 605 O
or 42 44 606 608 O
esophageal 45 55 609 619 B-treatment
resection 56 65 620 629 I-treatment
) 65 66 629 630 O
or 67 69 631 633 O
abdominal 70 79 634 643 O
( 80 81 644 645 O
laparotomy 81 91 645 655 B-treatment
with 92 96 656 660 O
organ 97 102 661 666 O
resection 103 112 667 676 O
) 112 113 676 677 O
operation 114 123 678 687 O
must 124 128 688 692 O
have 129 133 693 697 O
occurred 134 142 698 706 O
at 143 145 707 709 O
least 146 151 710 715 O
28 152 154 716 718 B-lower_bound
days 155 159 719 723 I-lower_bound
before 160 166 724 730 O
study 167 172 731 736 O
enrollment 173 183 737 747 O

Autoimmune 0 10 748 758 B-chronic_disease
or 11 13 759 761 O
antibody 14 22 762 770 B-chronic_disease
- 22 23 770 771 I-chronic_disease
mediated 23 31 771 779 I-chronic_disease
disease 32 39 780 787 I-chronic_disease
, 39 40 787 788 O
including 41 50 789 798 O
but 51 54 799 802 O
not 55 58 803 806 O
limited 59 66 807 814 O
to 67 69 815 817 O
systemic 70 78 818 826 B-chronic_disease
lupus 79 84 827 832 I-chronic_disease
erythematosus 85 98 833 846 I-chronic_disease
, 98 99 846 847 O
rheumatoid 100 110 848 858 B-chronic_disease
arthritis 111 120 859 868 I-chronic_disease
, 120 121 868 869 O
ulcerative 122 132 870 880 B-chronic_disease
colitis 133 140 881 888 I-chronic_disease
, 140 141 888 889 O
Crohn 142 147 890 895 B-chronic_disease
's 147 149 895 897 I-chronic_disease
disease 150 157 898 905 I-chronic_disease
, 157 158 905 906 O
and 159 162 907 910 O
temporal 163 171 911 919 B-chronic_disease
arteritis 172 181 920 929 I-chronic_disease

Bilirubin 0 9 930 939 B-clinical_variable
≤ 10 11 940 941 O
1.5x 12 16 942 946 B-upper_bound
upper 17 22 947 952 I-upper_bound
limit 23 28 953 958 I-upper_bound
of 29 31 959 961 I-upper_bound
normal 32 38 962 968 I-upper_bound
( 39 40 969 970 I-upper_bound
ULN 40 43 970 973 I-upper_bound
) 43 44 973 974 I-upper_bound

Breast 0 6 975 981 B-cancer
cancer 7 13 982 988 I-cancer
metastatic 14 24 989 999 B-cancer
to 25 27 1000 1002 O
the 28 31 1003 1006 O
pleura 32 38 1007 1013 O
that 39 43 1014 1018 O
extends 44 51 1019 1026 O
outside 52 59 1027 1034 O
of 60 62 1035 1037 O
the 63 66 1038 1041 O
pleura 67 73 1042 1048 O
requiring 74 83 1049 1058 O
immediate 84 93 1059 1068 O
therapy 94 101 1069 1076 B-treatment

Chemotherapy 0 12 1077 1089 B-treatment
must 13 17 1090 1094 O
have 18 22 1095 1099 O
been 23 27 1100 1104 O
completed 28 37 1105 1114 O
at 38 40 1115 1117 O
least 41 46 1118 1123 O
7 47 48 1124 1125 B-upper_bound
days 49 53 1126 1130 I-upper_bound
prior 54 59 1131 1136 I-upper_bound
to 60 62 1137 1139 O
leukapheresis 63 76 1140 1153 B-chronic_disease

Chemotherapy 0 12 1154 1166 B-treatment
, 12 13 1166 1167 O
targeted 14 22 1168 1176 B-treatment
therapy 23 30 1177 1184 I-treatment
( 31 32 1185 1186 O
such 32 36 1186 1190 O
as 37 39 1191 1193 O
a 40 41 1194 1195 O
tyrosine 42 50 1196 1204 B-treatment
kinase 51 57 1205 1211 I-treatment
inhibitor 58 67 1212 1221 I-treatment
) 67 68 1221 1222 O
or 69 71 1223 1225 O
radiotherapy 72 84 1226 1238 B-treatment
must 85 89 1239 1243 O
have 90 94 1244 1248 O
been 95 99 1249 1253 O
completed 100 109 1254 1263 O
at 110 112 1264 1266 O
least 113 118 1267 1272 O
14 119 121 1273 1275 B-lower_bound
days 122 126 1276 1280 I-lower_bound
prior 127 132 1281 1286 I-lower_bound
to 133 135 1287 1289 O
administration 136 150 1290 1304 O
of 151 153 1305 1307 O
T 154 155 1308 1309 O
cells 156 161 1310 1315 O

Clinically 0 10 1316 1326 O
significant 11 22 1327 1338 O
cardiac 23 30 1339 1346 B-chronic_disease
disease 31 38 1347 1354 I-chronic_disease
( 39 40 1355 1356 O
New 40 43 1356 1359 B-clinical_variable
York 44 48 1360 1364 I-clinical_variable
Heart 49 54 1365 1370 I-clinical_variable
Association 55 66 1371 1382 I-clinical_variable
class 67 72 1383 1388 B-lower_bound
III 73 76 1389 1392 I-lower_bound
/ 76 77 1392 1393 O
IV 77 79 1393 1395 B-upper_bound
) 79 80 1395 1396 O
or 81 83 1397 1399 O
severe 84 90 1400 1406 O
debilitating 91 103 1407 1419 O
pulmonary 104 113 1420 1429 B-chronic_disease
disease 114 121 1430 1437 I-chronic_disease

Continuation 0 12 1438 1450 O
of 13 15 1451 1453 O
hormonal 16 24 1454 1462 B-treatment
therapy 25 32 1463 1470 I-treatment
( 33 34 1471 1472 O
ie 34 36 1472 1474 O
for 37 40 1475 1478 O
breast 41 47 1479 1485 B-cancer
cancer 48 54 1486 1492 I-cancer
) 54 55 1492 1493 O

Karnofsky 0 9 1494 1503 B-clinical_variable
performance 10 21 1504 1515 I-clinical_variable
status 22 28 1516 1522 I-clinical_variable
≥70 29 32 1523 1526 O
% 32 33 1526 1527 I-lower_bound

Negative 0 8 1528 1536 O
screen 9 15 1537 1543 O
for 16 19 1544 1547 O
human 20 25 1548 1553 B-chronic_disease
immunodeficiency 26 42 1554 1570 I-chronic_disease
virus 43 48 1571 1576 I-chronic_disease
( 49 50 1577 1578 I-chronic_disease
HIV 50 53 1578 1581 I-chronic_disease
) 53 54 1581 1582 I-chronic_disease
, 54 55 1582 1583 O
hepatitis 56 65 1584 1593 B-chronic_disease
B 66 67 1594 1595 I-chronic_disease
virus 68 73 1596 1601 O
( 74 75 1602 1603 O
HBV 75 78 1603 1606 O
) 78 79 1606 1607 O
antigen 80 87 1608 1615 O
, 87 88 1615 1616 O
and 89 92 1617 1620 O
hepatitis 93 102 1621 1630 B-chronic_disease
C 103 104 1631 1632 I-chronic_disease
virus 105 110 1633 1638 O
( 111 112 1639 1640 O
HCV 112 115 1640 1643 O
) 115 116 1643 1644 O

No 0 2 1645 1647 O
free 3 7 1648 1652 O
- 7 8 1652 1653 O
flowing 8 15 1653 1660 O
pleural 16 23 1661 1668 O
effusion 24 32 1669 1677 O
: 32 33 1677 1678 O
an 34 36 1679 1681 O
Interventional 37 51 1682 1696 O
Radiologist 52 63 1697 1708 O
has 64 67 1709 1712 O
agreed 68 74 1713 1719 O
that 75 79 1720 1724 O
radiology 80 89 1725 1734 O
- 89 90 1734 1735 O
guided 90 96 1735 1741 O
intrapleural 97 109 1742 1754 B-treatment
or 110 112 1755 1757 I-treatment
peritumoral 113 124 1758 1769 I-treatment
injection 125 134 1770 1779 I-treatment
of 135 137 1780 1782 O
the 138 141 1783 1786 O
CAR 142 145 1787 1790 B-treatment
T 146 147 1791 1792 I-treatment
cells 148 153 1793 1798 I-treatment
is 154 156 1799 1801 O
feasible 157 165 1802 1810 O

Non 0 3 1811 1814 B-cancer
- 3 4 1814 1815 I-cancer
small 4 9 1815 1820 I-cancer
cell 10 14 1821 1825 I-cancer
lung 15 19 1826 1830 I-cancer
cancer 20 26 1831 1837 I-cancer
metastatic 27 37 1838 1848 O
to 38 40 1849 1851 O
the 41 44 1852 1855 O
pleura 45 51 1856 1862 O
that 52 56 1863 1867 O
extends 57 64 1868 1875 O
outside 65 72 1876 1883 O
of 73 75 1884 1886 O
the 76 79 1887 1890 O
pleura 80 86 1891 1897 O
requiring 87 96 1898 1907 O
immediate 97 106 1908 1917 O
therapy 107 114 1918 1925 B-treatment

Patients 0 8 1926 1934 O
currently 9 18 1935 1944 O
receiving 19 28 1945 1954 O
treatment 29 38 1955 1964 B-treatment
for 39 42 1965 1968 O
concurrent 43 53 1969 1979 O
active 54 60 1980 1986 B-cancer
malignancy 61 71 1987 1997 I-cancer
Continuation 72 84 1998 2010 O
of 85 87 2011 2013 O
hormonal 88 96 2014 2022 B-treatment
therapy 97 104 2023 2030 I-treatment
( 105 106 2031 2032 O
i.e. 106 110 2032 2036 O
for 111 114 2037 2040 O
breast 115 121 2041 2047 B-cancer
cancer 122 128 2048 2054 I-cancer
) 128 129 2054 2055 O

Patients 0 8 2056 2064 O
who 9 12 2065 2068 O
have 13 17 2069 2073 O
undergone 18 27 2074 2083 O
diagnostic 28 38 2084 2094 O
VATS 39 43 2095 2099 B-treatment
or 44 46 2100 2102 O
laparoscopy 47 58 2103 2114 B-treatment

Patients 0 8 2115 2123 O
with 9 13 2124 2128 O
MPD 14 17 2129 2132 B-chronic_disease
aged 18 22 2133 2137 B-age
≥18 23 26 2138 2141 O
years 27 32 2142 2147 I-lower_bound

Patients 0 8 2148 2156 O
with 9 13 2157 2161 O
a 14 15 2162 2163 O
functional 16 26 2164 2174 O
pleural 27 34 2175 2182 B-treatment
catheter 35 43 2183 2191 I-treatment
already 44 51 2192 2199 O
in 52 54 2200 2202 O
place 55 60 2203 2208 O
are 61 64 2209 2212 O
eligible 65 73 2213 2221 O
for 74 77 2222 2225 O
the 78 81 2226 2229 O
study 82 87 2230 2235 O
, 87 88 2235 2236 O
as 89 91 2237 2239 O
long 92 96 2240 2244 O
as 97 99 2245 2247 O
there 100 105 2248 2253 O
are 106 109 2254 2257 O
no 110 112 2258 2260 O
clinical 113 121 2261 2269 O
concerns 122 130 2270 2278 O
of 131 133 2279 2281 O
infection 134 143 2282 2291 B-chronic_disease

Patients 0 8 2292 2300 O
with 9 13 2301 2305 O
a 14 15 2306 2307 O
history 16 23 2308 2315 O
of 24 26 2316 2318 O
hypothyroidism 27 41 2319 2333 B-chronic_disease

Platelet 0 8 2334 2342 B-clinical_variable
count 9 14 2343 2348 I-clinical_variable
≥100,000 15 23 2349 2357 O
platelets 24 33 2358 2367 O
/ 33 34 2367 2368 O
mm3 34 37 2368 2371 O
Lab 38 41 2372 2375 O
requirements 42 54 2376 2388 O
( 55 56 2389 2390 O
serum 56 61 2390 2395 O
chemistry 62 71 2396 2405 O
) 71 72 2405 2406 O

Pregnant 0 8 2407 2415 B-pregnancy

Prior 0 5 2416 2421 O
history 6 13 2422 2429 O
of 14 16 2430 2432 O
seizure 17 24 2433 2440 B-chronic_disease
disorder 25 33 2441 2449 I-chronic_disease

Prior 0 5 2450 2455 B-treatment
immunotherapy 6 19 2456 2469 I-treatment
with 20 24 2470 2474 I-treatment
checkpoint 25 35 2475 2485 I-treatment
blockade 36 44 2486 2494 I-treatment
( 45 46 2495 2496 O
i.e. 46 50 2496 2500 O
PD1 51 54 2501 2504 B-treatment
inhibitor 55 64 2505 2514 I-treatment
, 64 65 2514 2515 O
PDL1 66 70 2516 2520 B-treatment
inhibitor 71 80 2521 2530 I-treatment
or 81 83 2531 2533 O
CTL4 84 88 2534 2538 B-treatment
- 88 89 2538 2539 I-treatment
antagonist 89 99 2539 2549 I-treatment
or 100 102 2550 2552 O
similar 103 110 2553 2560 O
agent 111 116 2561 2566 O
) 116 117 2566 2567 O
must 118 122 2568 2572 O
have 123 127 2573 2577 O
been 128 132 2578 2582 O
completed 133 142 2583 2592 O
more 143 147 2593 2597 O
than 148 152 2598 2602 O
1 153 154 2603 2604 B-lower_bound
month 155 160 2605 2610 I-lower_bound
prior 161 166 2611 2616 I-lower_bound
to 167 169 2617 2619 O
the 170 173 2620 2623 O
T 174 175 2624 2625 B-treatment
cell 176 180 2626 2630 I-treatment
infusion 181 189 2631 2639 I-treatment

Prior 0 5 2640 2645 B-treatment
immunotherapy 6 19 2646 2659 I-treatment
with 20 24 2660 2664 I-treatment
checkpoint 25 35 2665 2675 I-treatment
blockade 36 44 2676 2684 I-treatment
( 45 46 2685 2686 O
i.e. 46 50 2686 2690 O
PD1 51 54 2691 2694 B-treatment
inhibitor 55 64 2695 2704 I-treatment
, 64 65 2704 2705 O
PDL1 66 70 2706 2710 B-treatment
inhibitor 71 80 2711 2720 I-treatment
or 81 83 2721 2723 O
CTL4 84 88 2724 2728 B-treatment
- 88 89 2728 2729 I-treatment
antagonist 89 99 2729 2739 I-treatment
or 100 102 2740 2742 O
similar 103 110 2743 2750 O
agent 111 116 2751 2756 O
) 116 117 2756 2757 O
must 118 122 2758 2762 O
have 123 127 2763 2767 O
been 128 132 2768 2772 O
completed 133 142 2773 2782 O
more 143 147 2783 2787 O
than 148 152 2788 2792 O
1 153 154 2793 2794 B-lower_bound
month1prior 155 166 2795 2806 I-lower_bound
to 167 169 2807 2809 O
the 170 173 2810 2813 O
T 174 175 2814 2815 B-treatment
cell 176 180 2816 2820 I-treatment
infusion 181 189 2821 2829 I-treatment

Serum 0 5 2830 2835 B-clinical_variable
alanine 6 13 2836 2843 I-clinical_variable
aminotransferase 14 30 2844 2860 I-clinical_variable
and 31 34 2861 2864 I-clinical_variable
serum 35 40 2865 2870 I-clinical_variable
aspartate 41 50 2871 2880 I-clinical_variable
aminotransferase 51 67 2881 2897 I-clinical_variable
( 68 69 2898 2899 I-clinical_variable
ALT 69 72 2899 2902 I-clinical_variable
/ 72 73 2902 2903 I-clinical_variable
AST 73 76 2903 2906 I-clinical_variable
) 76 77 2906 2907 I-clinical_variable
≤.5x 78 82 2908 2912 O
ULN 83 86 2913 2916 I-upper_bound

Serum 0 5 2917 2922 B-clinical_variable
creatinine 6 16 2923 2933 I-clinical_variable
≤ 17 18 2934 2935 O
1.5x 19 23 2936 2940 O
ULN 24 27 2941 2944 O
or 28 30 2945 2947 O
Cr 31 33 2948 2950 B-clinical_variable
> 34 35 2951 2952 O
1.5x 36 40 2953 2957 O
ULN 41 44 2958 2961 O
, 44 45 2961 2962 O
but 46 49 2963 2966 O
calculated 50 60 2967 2977 B-clinical_variable
clearances 61 71 2978 2988 I-clinical_variable
of 72 74 2989 2991 O
> 75 76 2992 2993 O
60 76 78 2993 2995 B-lower_bound

Subjects 0 8 2996 3004 O
and 9 12 3005 3008 O
their 13 18 3009 3014 O
partners 19 27 3015 3023 O
with 28 32 3024 3028 O
reproductive 33 45 3029 3041 O
potential 46 55 3042 3051 O
must 56 60 3052 3056 O
agree 61 66 3057 3062 B-contraception_consent
to 67 69 3063 3065 I-contraception_consent
use 70 73 3066 3069 I-contraception_consent
an 74 76 3070 3072 I-contraception_consent
effective 77 86 3073 3082 I-contraception_consent
form 87 91 3083 3087 I-contraception_consent
of 92 94 3088 3090 I-contraception_consent
contraception 95 108 3091 3104 I-contraception_consent
during 109 115 3105 3111 O
the 116 119 3112 3115 O
period 120 126 3116 3122 O
of 127 129 3123 3125 O
drug 130 134 3126 3130 O
administration 135 149 3131 3145 O
and 150 153 3146 3149 O
for 154 157 3150 3153 O
4 158 159 3154 3155 B-upper_bound
weeks 160 165 3156 3161 I-upper_bound
after 166 171 3162 3167 I-upper_bound
completion 172 182 3168 3178 O
of 183 185 3179 3181 O
the 186 189 3182 3185 O
last 190 194 3186 3190 O
administration 195 209 3191 3205 O
of 210 212 3206 3208 O
the 213 216 3209 3212 O
study 217 222 3213 3218 B-treatment
drug 223 227 3219 3223 I-treatment
. 227 228 3223 3224 O
An 229 231 3225 3227 O
effective 232 241 3228 3237 O
form 242 246 3238 3242 O
of 247 249 3243 3245 O
contraception 250 263 3246 3259 O
is 264 266 3260 3262 O
defined 267 274 3263 3270 O
as 275 277 3271 3273 O
oral 278 282 3274 3278 B-contraception_consent
contraceptives 283 297 3279 3293 I-contraception_consent
plus 298 302 3294 3298 O
1 303 304 3299 3300 O
form 305 309 3301 3305 O
of 310 312 3306 3308 O
barrier 313 320 3309 3316 B-contraception_consent
or 321 323 3317 3319 I-contraception_consent
double 324 330 3320 3326 I-contraception_consent
- 330 331 3326 3327 I-contraception_consent
barrier 331 338 3327 3334 I-contraception_consent
method 339 345 3335 3341 I-contraception_consent
contraception 346 359 3342 3355 I-contraception_consent
( 360 361 3356 3357 O
condom 361 367 3357 3363 B-contraception_consent
with 368 372 3364 3368 I-contraception_consent
spermicide 373 383 3369 3379 I-contraception_consent
or 384 386 3380 3382 O
condom 387 393 3383 3389 B-contraception_consent
with 394 398 3390 3394 I-contraception_consent
diaphragm 399 408 3395 3404 I-contraception_consent
) 408 409 3404 3405 O

Topical 0 7 3406 3413 B-treatment
, 7 8 3413 3414 O
nasal 9 14 3415 3420 B-treatment
, 14 15 3420 3421 O
and 16 19 3422 3425 O
inhaled 20 27 3426 3433 B-treatment
steroids 28 36 3434 3442 I-treatment

Untreated 0 9 3443 3452 O
or 10 12 3453 3455 O
active 13 19 3456 3462 O
CNS 20 23 3463 3466 B-cancer
metastases 24 34 3467 3477 I-cancer
( 35 36 3478 3479 O
progressing 36 47 3479 3490 O
or 48 50 3491 3493 O
requiring 51 60 3494 3503 O
anticonvulsants 61 76 3504 3519 B-treatment
or 77 79 3520 3522 O
corticosteroids 80 95 3523 3538 B-treatment
for 96 99 3539 3542 O
symptomatic 100 111 3543 3554 O
control 112 119 3555 3562 O
) 119 120 3562 3563 O

White 0 5 3564 3569 B-clinical_variable
blood 6 11 3570 3575 I-clinical_variable
cell 12 16 3576 3580 I-clinical_variable
( 17 18 3581 3582 I-clinical_variable
WBC 18 21 3582 3585 I-clinical_variable
) 21 22 3585 3586 I-clinical_variable
count 23 28 3587 3592 I-clinical_variable
≥3000 29 34 3593 3598 O
cells 35 40 3599 3604 I-lower_bound
/ 40 41 3604 3605 I-lower_bound
mm3 41 44 3605 3608 I-lower_bound

lactating 0 9 3609 3618 O
women 10 15 3619 3624 B-gender

